Explore our comprehensive coverage of weight loss, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.
A new obesity drug showing dramatic weight loss results is reshaping public health strategy, raising questions about cost, long-term efficacy, and the...
Read Full Story →
Nutrition & FitnessGLP-1 medications have reached 21% of U.S. households while causing 15-40% lean muscle mass loss and...
Nutrition & FitnessA leading obesity medicine specialist debunks widespread myths surrounding GLP-1 medications, affirm...
Medical ResearchA randomised controlled trial published in Nature Medicine reveals that a daily postbiotic supplemen...
Healthcare PolicyThe Centers for Medicare & Medicaid Services has launched the GLP-1 Bridge Program, a short-term dem...
Nutrition & FitnessA landmark University of Oxford study published in The BMJ reveals that discontinuing weight-loss dr...
Nutrition & FitnessMedicare's groundbreaking GLP-1 Bridge program launched July 1, 2026, providing eligible seniors acc...
